Form EFFECT Decoy Therapeutics Inc.
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | July 17, 2026 5:00 P.M. |
| Form: | S-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Decoy Therapeutics elects Moderna executive to its board
- Yum! Brands Appoints Nai De Leon as Chief People & Culture Officer
- Volt-Age, Concordia research program and Volatus Aerospace join forces to advance energy technologies for uncrewed aircraft systems
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share